World Journal of Gastrointestinal Surgery - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Huang XY, Zhong QH, Kuang YY, Li ZJ, Huang BJ, He YJ, Zhu MM, Guan Q, Li XY, Qin QY, Ma TH. Thalidomide for refractory hemorrhagic chronic radiation proctitis secondary to pelvic malignancy radiotherapy: A phase II clinical trial. World J Gastroenterol 2026; 32(14): 116529 [DOI: 10.3748/wjg.v32.i14.116529]
URL:	https://www.wjgnet.com/1948-9366/full/v32/i14/116529.htm

(42) (37) (0) (0) (0) (24) (1) (1) (1180) (1)

Number	Citing Articles
1	Ya Deng, Zhi-Min Du, Hong-Fang Li, Fu-Shan Tang. Thalidomide for refractory hemorrhagic chronic radiation proctitis: Bridging the gap between symptom control and disease-modifying therapy. World Journal of Gastroenterology 2026; 32(38): 120289 doi: 10.3748/wjg.120289 Abstract(15) \| Core Tip(15) \| Full Article(HTML)(26) \| Full Article (PDF)-401K(2) \| Full Article with Cover (PDF)-709K(1) \| Full Article (XML)-53K(5) \| Audio-536K(0) \| Peer-Review Report-259K(7) \| Answering Reviewers-147K(8) \| Times Cited (0) \| Total Visits (34) \| Open

Number

Citing Articles

Ya Deng, Zhi-Min Du, Hong-Fang Li, Fu-Shan Tang. Thalidomide for refractory hemorrhagic chronic radiation proctitis: Bridging the gap between symptom control and disease-modifying therapy. World Journal of Gastroenterology 2026; 32(38): 120289 doi: 10.3748/wjg.120289

Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.